My very basic interpretation. When the safety protocols were designed with all of these trials they were unique. They found after these last 2 trials that they were too rigorous and made it harder for trial participants. As there is other drug trial competition in prader willi (unlike the last 2), it could make it harder to get participants in a competitive market. Hence the meeting (Q4?) With the FDA to simplify it and be more competitive. Thats the gist I took from it anyway.
- Forums
- ASX - By Stock
- NEU
- Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins, page-112
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
HCH
Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.91 |
Change
0.610(3.16%) |
Mkt cap ! $2.516B |
Open | High | Low | Value | Volume |
$19.80 | $20.00 | $19.40 | $2.636M | 133.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 446 | $19.89 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.91 | 590 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 92 | 19.890 |
14 | 292 | 19.880 |
5 | 366 | 19.870 |
3 | 179 | 19.860 |
7 | 362 | 19.850 |
Price($) | Vol. | No. |
---|---|---|
19.900 | 150 | 5 |
19.910 | 339 | 6 |
19.920 | 576 | 7 |
19.930 | 296 | 4 |
19.940 | 520 | 4 |
Last trade - 15.31pm 11/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |